BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) announced its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.
BioForce Nanosciences Stock Up 0.1%
BFNH opened at $6.69 on Tuesday. The company has a market capitalization of $254.69 million, a price-to-earnings ratio of 669.67 and a beta of 0.79. The firm has a 50-day moving average price of $7.70 and a 200-day moving average price of $2.80. BioForce Nanosciences has a twelve month low of $0.18 and a twelve month high of $10.99.
BioForce Nanosciences Company Profile
BioForce Nanosciences, Inc developed nanotechnology tools and systems for life-science and biotechnology applications. Its technology was designed to manipulate, deposit and analyze very small quantities of biological materials, supporting research in areas such as proteomics, genomics, diagnostics and drug discovery.
The company’s product portfolio included the Nano eNabler molecular printer, a platform intended to create precise arrays of proteins, DNA and other biomolecules on laboratory substrates.
Read More
- Five stocks we like better than BioForce Nanosciences
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
